Compositions and methods for targeted cytokine delivery
US-2024376169-A1 · Nov 14, 2024 · US
Cytokines; Lymphokines; Interferons
Cytokines; Lymphokines; Interferons · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/52 |
| Official title | Cytokines; Lymphokines; Interferons |
| Display label | Cytokines; Lymphokines; Interferons |
| Total patents | 587 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 42 |
| 2016 | 51 |
| 2017 | 44 |
| 2018 | 52 |
| 2019 | 61 |
| 2020 | 41 |
| 2021 | 59 |
| 2022 | 59 |
| 2023 | 61 |
| 2024 | 57 |
| 2025 | 48 |
| 2026 | 12 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
US-9504738-B2 · Nov 29, 2016 · US
Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
US-9493845-B2 · Nov 15, 2016 · US
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US-9446155-B2 · Sep 20, 2016 · US
Novel immunoconjugates
US-2016263240-A1 · Sep 15, 2016 · US
Colostrum/milk protein compositions
US-2016257730-A1 · Sep 8, 2016 · US
Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function
US-9433686-B2 · Sep 6, 2016 · US
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US-9408926-B2 · Aug 9, 2016 · US
Use of cardiotrophin to modulate stem cell proliferation
US-2016222352-A1 · Aug 4, 2016 · US
FROG/TOAD conditionally silenced vectors for hypoxia gene therapy
US-9394526-B2 · Jul 19, 2016 · US
Therapeutic agents comprising fusions of growth hormone and elastic peptides
US-9328154-B2 · May 3, 2016 · US
Targeting vector-phospholipid conjugates
US-9295737-B2 · Mar 29, 2016 · US
α/β-peptide mimics of Z-domain peptides
US-9284362-B2 · Mar 15, 2016 · US
Biological active proteins having increased in vivo and/or in vitro stability
US-9260494-B2 · Feb 16, 2016 · US
Purification and Purity Assessment of RNA Molecules Synthesized with Modified Nucleosides
US-2016032316-A1 · Feb 4, 2016 · US
Ron compositions and methods of use thereof
US-2016032013-A1 · Feb 4, 2016 · US
Cell Penetrating Peptide, Conjugate Comprising Same, and Composition Comprising Conjugate
US-2016002613-A1 · Jan 7, 2016 · US
Myonectin (CTRP15), compositions comprising same, and methods of use
US-9228005-B2 · Jan 5, 2016 · US
Method of inhibiting binding or activity of MIF by administering a MIF antagonist
US-9221903-B2 · Dec 29, 2015 · US
ZCYTOR17 heterodimeric cytokine receptor
US-9212213-B2 · Dec 15, 2015 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/52?
- CPC C07K14/52 is the Cooperative Patent Classification code for “Cytokines; Lymphokines; Interferons.”
- How many patents are filed under CPC C07K14/52 (Cytokines; Lymphokines; Interferons)?
- Our database includes 587 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/52 growing?
- Publication counts under this code: 57 in 2024 vs 48 in 2025 (latest complete years).